Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,110 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

NCT01743989

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +17 more
Locations
  • Novartis Investigative Site Linz, Upper Austria, Austria
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Linz, Austria
View all 208 locations
View Trial Details
Completed

Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

NCT01690520

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +22 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

NCT03451084

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • 1 Site Louisville, Kentucky, United States
  • 1 Site Albury, New South Wales, Australia
  • 3 Sites Darlinghurst, New South Wales, Australia
  • 1 Site Waratah, New South Wales, Australia
View Trial Details
Completed

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

NCT00980018

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States
  • USC Norris Cancer Center LAC & USC Medical Center Los Angeles, California, United States
  • Southwest Cancer Care Murrieta Poway, California, United States
View all 23 locations
View Trial Details
Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

NCT00109707

Conditions
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
View all 101 locations
View Trial Details
Completed

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

NCT00171158

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +18 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Faber Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Poitiers, France
View Trial Details
Completed

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

NCT01822509

Conditions
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 13 locations
View Trial Details

Related conditions